Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_double_gel_72h.class.cls #double_gel_8d_versus_double_gel_72h_repos |
Phenotype | class.cls#double_gel_8d_versus_double_gel_72h_repos |
Upregulated in class | double_gel_8d |
GeneSet | NETPATH_IL_3_PATHWAY_UP |
Enrichment Score (ES) | 0.61621493 |
Normalized Enrichment Score (NES) | 1.8325408 |
Nominal p-value | 0.0035842294 |
FDR q-value | 0.027047085 |
FWER p-Value | 0.909 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | CCL2 | CCL2 Entrez,  Source | chemokine (C-C motif) ligand 2 | 76 | 0.477 | 0.1590 | Yes |
2 | FOS | FOS Entrez,  Source | v-fos FBJ murine osteosarcoma viral oncogene homolog | 142 | 0.371 | 0.2820 | Yes |
3 | CCL3 | CCL3 Entrez,  Source | chemokine (C-C motif) ligand 3 | 183 | 0.333 | 0.3941 | Yes |
4 | CD69 | CD69 Entrez,  Source | CD69 molecule | 898 | 0.129 | 0.3851 | Yes |
5 | CCR1 | CCR1 Entrez,  Source | chemokine (C-C motif) receptor 1 | 979 | 0.123 | 0.4217 | Yes |
6 | IL1B | IL1B Entrez,  Source | interleukin 1, beta | 1014 | 0.121 | 0.4608 | Yes |
7 | SPP1 | SPP1 Entrez,  Source | secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1) | 1105 | 0.114 | 0.4935 | Yes |
8 | CCL7 | CCL7 Entrez,  Source | chemokine (C-C motif) ligand 7 | 1159 | 0.111 | 0.5280 | Yes |
9 | IL3RA | IL3RA Entrez,  Source | interleukin 3 receptor, alpha (low affinity) | 1257 | 0.107 | 0.5576 | Yes |
10 | CISH | CISH Entrez,  Source | cytokine inducible SH2-containing protein | 1573 | 0.090 | 0.5651 | Yes |
11 | CSF1 | CSF1 Entrez,  Source | colony stimulating factor 1 (macrophage) | 1683 | 0.086 | 0.5864 | Yes |
12 | ANXA2 | ANXA2 Entrez,  Source | annexin A2 | 1825 | 0.079 | 0.6032 | Yes |
13 | TGFB1 | TGFB1 Entrez,  Source | transforming growth factor, beta 1 (Camurati-Engelmann disease) | 2079 | 0.071 | 0.6086 | Yes |
14 | BCL2 | BCL2 Entrez,  Source | B-cell CLL/lymphoma 2 | 2324 | 0.064 | 0.6123 | Yes |
15 | HBB | HBB Entrez,  Source | hemoglobin, beta | 2720 | 0.055 | 0.6015 | Yes |
16 | TNF | TNF Entrez,  Source | tumor necrosis factor (TNF superfamily, member 2) | 2770 | 0.053 | 0.6162 | Yes |
17 | IL6R | IL6R Entrez,  Source | interleukin 6 receptor | 3241 | 0.044 | 0.5960 | No |
18 | CCL4 | CCL4 Entrez,  Source | chemokine (C-C motif) ligand 4 | 3468 | 0.039 | 0.5926 | No |
19 | MATK | MATK Entrez,  Source | megakaryocyte-associated tyrosine kinase | 4259 | 0.026 | 0.5423 | No |
20 | BCL2L1 | BCL2L1 Entrez,  Source | BCL2-like 1 | 4270 | 0.026 | 0.5504 | No |
21 | MCL1 | MCL1 Entrez,  Source | myeloid cell leukemia sequence 1 (BCL2-related) | 4307 | 0.025 | 0.5564 | No |
22 | KIT | KIT Entrez,  Source | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 4345 | 0.025 | 0.5622 | No |
23 | SOCS3 | SOCS3 Entrez,  Source | suppressor of cytokine signaling 3 | 5260 | 0.012 | 0.4975 | No |
24 | ODC1 | ODC1 Entrez,  Source | ornithine decarboxylase 1 | 5974 | 0.002 | 0.4448 | No |
25 | TGFA | TGFA Entrez,  Source | transforming growth factor, alpha | 7317 | -0.014 | 0.3490 | No |
26 | NFIL3 | NFIL3 Entrez,  Source | nuclear factor, interleukin 3 regulated | 7648 | -0.019 | 0.3307 | No |
27 | MYC | MYC Entrez,  Source | v-myc myelocytomatosis viral oncogene homolog (avian) | 7715 | -0.020 | 0.3325 | No |
28 | RARA | RARA Entrez,  Source | retinoic acid receptor, alpha | 8732 | -0.034 | 0.2679 | No |
29 | SOCS2 | SOCS2 Entrez,  Source | suppressor of cytokine signaling 2 | 8876 | -0.036 | 0.2695 | No |
30 | SOCS1 | SOCS1 Entrez,  Source | suppressor of cytokine signaling 1 | 8877 | -0.036 | 0.2819 | No |
31 | CD86 | CD86 Entrez,  Source | CD86 molecule | 10637 | -0.065 | 0.1722 | No |
32 | PIM1 | PIM1 Entrez,  Source | pim-1 oncogene | 11624 | -0.090 | 0.1291 | No |